Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Loading SNTA News...
Health Technology » Pharmaceuticals Other
|VRX||Valeant Pharmaceuticals International, Inc.||1.76%||15.61||8.4%||$350.60m|
|SHPG||Shire PLC Sponsored ADR||-2.05%||172.77||0.5%||$214.39m|
|PRGO||Perrigo Co. Plc||-0.22%||84.47||3.7%||$145.91m|
|GWPH||GW Pharmaceuticals PLC Sponsored ADR||2.33%||120.19||11.4%||$87.08m|
|ENDP||Endo International Plc||-0.06%||15.86||5.9%||$83.30m|
|UTHR||United Therapeutics Corporation||5.69%||136.73||20.3%||$75.46m|
|PRXL||PAREXEL International Corporation||4.45%||62.62||5.8%||$71.68m|
|JAZZ||Jazz Pharmaceuticals Plc||2.21%||103.87||2.7%||$70.51m|
|HZNP||Horizon Pharma plc||2.75%||20.21||10.8%||$65.42m|
|ICPT||Intercept Pharmaceuticals, Inc.||2.52%||105.84||19.0%||$51.65m|
|EGRX||Eagle Pharmaceuticals, Inc.||2.48%||79.83||27.2%||$33.43m|
Synta Pharmaceuticals Corp. discovers, develops and commercializes pharmaceutical products. It focuses on the research, development and commercialization of oncology medicines that provides treatment to cancer patients. The company is also developing a proprietary platform for delivery of anti-cancer drugs directly to tumor cells, known as Hsp90-inhibitor drug conjugates. Synta Pharmaceuticals was founded by Safi R. Bahcall and Lan-Bo Chen in March 2000 and is headquartered in Lexington, MA.